LUNG
Pulmonx Corp.
NASDAQ · Healthcare · Medical - Devices · US
$2.07
+4.55%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.26
- Revenue estimate
- $21.9M
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- -$0.24
- EPS estimate
- -$0.28
- Revenue actual
- $22.8M
- Revenue estimate
- $22.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +16.3%
- Revenue beats (12Q)
- 9
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | -$0.28 | -$0.24 | Beat 14.29% | $22.8M |
| Apr 29, 2026 | -$0.33 | -$0.33 | In line | $20.6M |
| Mar 4, 2026 | -$0.39 | -$0.25 | Beat 35.90% | $22.6M |
| Nov 12, 2025 | -$0.40 | -$0.34 | Beat 15.00% | $21.5M |
| Jul 30, 2025 | -$0.40 | -$0.38 | Beat 5.00% | $23.9M |
| Apr 30, 2025 | -$0.37 | -$0.36 | Beat 2.70% | $22.5M |
| Feb 19, 2025 | -$0.45 | -$0.33 | Beat 26.67% | $23.8M |
| Oct 30, 2024 | -$0.43 | -$0.36 | Beat 16.28% | $20.4M |
| Jul 31, 2024 | -$0.41 | -$0.39 | Beat 4.88% | $20.8M |
| May 1, 2024 | -$0.43 | -$0.36 | Beat 16.28% | $18.9M |
| Feb 21, 2024 | -$0.39 | -$0.36 | Beat 7.69% | $19.3M |
| Aug 2, 2023 | -$0.43 | -$0.43 | In line | $17.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026